It can be postulated that the CCDC6 mutations identified in NSCLC patients can affect post-translational modifications of the CCDC6 protein, meaning either the phosphorylation that drives the CCDC6 localization in the nucleus or the stabilization of the protein in the cytosol [1]. Here, CCDC6 is linked to non-small cell lung carcinoma.